RGMP
Price:
$0.0001
Market Cap:
$2.29K
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody CC chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
Industry
Entertainment
IPO Date
2019-05-29
Stock Exchange
OTC
Ticker
RGMP
According to Regnum Corp.’s latest financial reports and current stock price. The company's current ROE is 101.39%. This represents a change of 511.42% compared to the average of 16.58% of the last 4 quarters.
The mean historical ROE of Regnum Corp. over the last ten years is 1.97%. The current 101.39% ROE has changed 5.06% with respect to the historical average. Over the past ten years (40 quarters), RGMP's ROE was at its highest in in the June 2020 quarter at 102.65%. The ROE was at its lowest in in the March 2020 quarter at -6471.43%.
Average
1.97%
Median
67.29%
Minimum
-473.70%
Maximum
233.51%
Discovering the peaks and valleys of Regnum Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 233.51%
Minimum Annual Increase = -10546.01%
Minimum Annual ROE = -473.70%
| Year | ROE | Change |
|---|---|---|
| 2022 | 67.29% | -5.34% |
| 2021 | 71.09% | -69.56% |
| 2020 | 233.51% | -149.30% |
| 2019 | -473.70% | -10546.01% |
| 2018 | 4.53% | -58.93% |
| 2017 | 11.04% | -88.96% |
The current ROE of Regnum Corp. (RGMP) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
123.96%
5-year avg
-19.46%
10-year avg
1.97%
Regnum Corp.’s ROE is greater than Ampio Pharmaceuticals, Inc. (-113.96%), less than IR Biosciences Holdings Inc. (47.28%), less than Bioasis Technologies Inc. (392.02%), less than GB Sciences, Inc. (28.02%), greater than Scorpius Holdings, Inc. (0.00%), greater than Lombard Medical, Inc. (-108.73%), less than Nexien BioPharma, Inc. (77.94%), less than GlobeStar Therapeutics Corporation (148.30%), greater than Neptune Wellness Solutions Inc. (-88.52%), greater than Golden Developing Solutions, Inc. (-267.95%),
| Company | ROE | Market cap |
|---|---|---|
| -113.96% | $207.88K | |
| 47.28% | $128.12K | |
| 392.02% | $7.94K | |
| 28.02% | $81.41K | |
| 0.00% | $12.39K | |
| -108.73% | $2.79K | |
| 77.94% | $7.08K | |
| 148.30% | $124.11K | |
| -88.52% | $453.00 | |
| -267.95% | $1.41K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Regnum Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Regnum Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Regnum Corp.'s ROE?
How is the ROE calculated for Regnum Corp. (RGMP)?
What is the highest ROE for Regnum Corp. (RGMP)?
What is the 3-year average ROE for Regnum Corp. (RGMP)?
What is the 5-year average ROE for Regnum Corp. (RGMP)?
How does the current ROE for Regnum Corp. (RGMP) compare to its historical average?